We emphasize: Strength Training Building lean muscle prevents metabolic decline post-GLP-1
Complete the online intake Answer a short medical questionnaire (about 5 minutes) covering your health history, goals, and current medications
The SUSTAIN and STEP trial data consistently showed cardiometabolic improvements in lipid profiles alongside weight loss, which is part of why semaglutide received approval for cardiovascular risk reduction in certain populations
Members gain access to continuously updated content on emerging peptides, comparative analyses of formulations like tirzepatide niacinamide versus standard options, and practical tools for tracking progress
In addition, people taking GLP1-RAs needed fewer procedures to restore blood flow to their legs
Its usefulness depends on the objective, the population and the baseline status